Third Harmonic Bio, Inc. (THRD)
NASDAQ: THRD · Real-Time Price · USD
5.17
+0.01 (0.29%)
At close: May 12, 2025, 4:00 PM
5.16
0.00 (-0.10%)
After-hours: May 12, 2025, 4:00 PM EDT
Third Harmonic Bio Market Cap
Third Harmonic Bio has a market cap or net worth of $233.31 million as of May 12, 2025. Its market cap has decreased by -49.48% in one year.
Market Cap
233.31M
Enterprise Value
-34.62M
1-Year Change
-49.48%
Ranking
Category
Stock Price
$5.17
Market Cap Chart
Since the IPO on September 15, 2022, Third Harmonic Bio's market cap has decreased from $657.80M to $233.31M, a decrease of -64.53%. That is a compound annual growth rate of -32.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 232.41M | -49.87% |
| Dec 31, 2024 | 463.65M | 4.71% |
| Dec 29, 2023 | 442.78M | 153.97% |
| Dec 30, 2022 | 174.34M | -73.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |